166 related articles for article (PubMed ID: 37756541)
1. Jagged1 Acts as an RBP-J Target and Feedback Suppresses TNF-Mediated Inflammatory Osteoclastogenesis.
Ng C; Qin Y; Xia Y; Hu X; Zhao B
J Immunol; 2023 Nov; 211(9):1340-1347. PubMed ID: 37756541
[TBL] [Abstract][Full Text] [Related]
2. RBP-J-Regulated miR-182 Promotes TNF-α-Induced Osteoclastogenesis.
Miller CH; Smith SM; Elguindy M; Zhang T; Xiang JZ; Hu X; Ivashkiv LB; Zhao B
J Immunol; 2016 Jun; 196(12):4977-86. PubMed ID: 27183593
[TBL] [Abstract][Full Text] [Related]
3. Intrinsic Restriction of TNF-Mediated Inflammatory Osteoclastogenesis and Bone Resorption.
Zhao B
Front Endocrinol (Lausanne); 2020; 11():583561. PubMed ID: 33133025
[TBL] [Abstract][Full Text] [Related]
4. TNF-induced osteoclastogenesis and inflammatory bone resorption are inhibited by transcription factor RBP-J.
Zhao B; Grimes SN; Li S; Hu X; Ivashkiv LB
J Exp Med; 2012 Feb; 209(2):319-34. PubMed ID: 22249448
[TBL] [Abstract][Full Text] [Related]
5. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
Binder N; Miller C; Yoshida M; Inoue K; Nakano S; Hu X; Ivashkiv LB; Schett G; Pernis A; Goldring SR; Ross FP; Zhao B
J Immunol; 2017 May; 198(9):3436-3447. PubMed ID: 28314855
[TBL] [Abstract][Full Text] [Related]
6. Lipopolysaccharide- TLR-4 Axis regulates Osteoclastogenesis independent of RANKL/RANK signaling.
AlQranei MS; Senbanjo LT; Aljohani H; Hamza T; Chellaiah MA
BMC Immunol; 2021 Mar; 22(1):23. PubMed ID: 33765924
[TBL] [Abstract][Full Text] [Related]
7. Regulatory network mediated by RBP-J/NFATc1-miR182 controls inflammatory bone resorption.
Inoue K; Hu X; Zhao B
FASEB J; 2020 Feb; 34(2):2392-2407. PubMed ID: 31908034
[TBL] [Abstract][Full Text] [Related]
8. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis.
Xia Y; Inoue K; Du Y; Baker SJ; Reddy EP; Greenblatt MB; Zhao B
Nat Commun; 2022 Jul; 13(1):3920. PubMed ID: 35798734
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-27 inhibits human osteoclastogenesis by abrogating RANKL-mediated induction of nuclear factor of activated T cells c1 and suppressing proximal RANK signaling.
Kalliolias GD; Zhao B; Triantafyllopoulou A; Park-Min KH; Ivashkiv LB
Arthritis Rheum; 2010 Feb; 62(2):402-13. PubMed ID: 20112358
[TBL] [Abstract][Full Text] [Related]
10. Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.
Jules J; Shi Z; Liu J; Xu D; Wang S; Feng X
J Biol Chem; 2010 Nov; 285(48):37427-35. PubMed ID: 20870724
[TBL] [Abstract][Full Text] [Related]
11. Characterization and Function of Tumor Necrosis Factor and Interleukin-6-Induced Osteoclasts in Rheumatoid Arthritis.
Yokota K; Sato K; Miyazaki T; Aizaki Y; Tanaka S; Sekikawa M; Kozu N; Kadono Y; Oda H; Mimura T
Arthritis Rheumatol; 2021 Jul; 73(7):1145-1154. PubMed ID: 33512089
[TBL] [Abstract][Full Text] [Related]
12. Role of Lysine-Specific Demethylase 1 in Metabolically Integrating Osteoclast Differentiation and Inflammatory Bone Resorption Through Hypoxia-Inducible Factor 1α and E2F1.
Doi K; Murata K; Ito S; Suzuki A; Terao C; Ishie S; Umemoto A; Murotani Y; Nishitani K; Yoshitomi H; Fujii T; Watanabe R; Hashimoto M; Murakami K; Tanaka M; Ito H; Park-Min KH; Ivashkiv LB; Morinobu A; Matsuda S
Arthritis Rheumatol; 2022 Jun; 74(6):948-960. PubMed ID: 35077015
[TBL] [Abstract][Full Text] [Related]
13. RBP-J imposes a requirement for ITAM-mediated costimulation of osteoclastogenesis.
Li S; Miller CH; Giannopoulou E; Hu X; Ivashkiv LB; Zhao B
J Clin Invest; 2014 Nov; 124(11):5057-73. PubMed ID: 25329696
[TBL] [Abstract][Full Text] [Related]
14. Differential regulation of osteoclastogenesis by Notch2/Delta-like 1 and Notch1/Jagged1 axes.
Sekine C; Koyanagi A; Koyama N; Hozumi K; Chiba S; Yagita H
Arthritis Res Ther; 2012 Mar; 14(2):R45. PubMed ID: 22390640
[TBL] [Abstract][Full Text] [Related]
15. Sappanone A inhibits RANKL-induced osteoclastogenesis in BMMs and prevents inflammation-mediated bone loss.
Choo YY; Tran PT; Min BS; Kim O; Nguyen HD; Kwon SH; Lee JH
Int Immunopharmacol; 2017 Nov; 52():230-237. PubMed ID: 28946117
[TBL] [Abstract][Full Text] [Related]
16. Intravenous Immunoglobulin (IVIG) Attenuates TNF-Induced Pathologic Bone Resorption and Suppresses Osteoclastogenesis by Inducing A20 Expression.
Lee MJ; Lim E; Mun S; Bae S; Murata K; Ivashkiv LB; Park-Min KH
J Cell Physiol; 2016 Feb; 231(2):449-458. PubMed ID: 26189496
[TBL] [Abstract][Full Text] [Related]
17. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells.
Bai S; Kopan R; Zou W; Hilton MJ; Ong CT; Long F; Ross FP; Teitelbaum SL
J Biol Chem; 2008 Mar; 283(10):6509-18. PubMed ID: 18156632
[TBL] [Abstract][Full Text] [Related]
18. Rheumatoid and pyrophosphate arthritis synovial fibroblasts induce osteoclastogenesis independently of RANKL, TNF and IL-6.
Dickerson TJ; Suzuki E; Stanecki C; Shin HS; Qui H; Adamopoulos IE
J Autoimmun; 2012 Dec; 39(4):369-76. PubMed ID: 22867712
[TBL] [Abstract][Full Text] [Related]
19. Sanguiin H-6, a constituent of Rubus parvifolius L., inhibits receptor activator of nuclear factor-κB ligand-induced osteoclastogenesis and bone resorption in vitro and prevents tumor necrosis factor-α-induced osteoclast formation in vivo.
Sakai E; Aoki Y; Yoshimatsu M; Nishishita K; Iwatake M; Fukuma Y; Okamoto K; Tanaka T; Tsukuba T
Phytomedicine; 2016 Jul; 23(8):828-37. PubMed ID: 27288918
[TBL] [Abstract][Full Text] [Related]
20. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis.
Romas E; Gillespie MT; Martin TJ
Bone; 2002 Feb; 30(2):340-6. PubMed ID: 11856640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
